Annual report [Section 13 and 15(d), not S-K Item 405]

Segment Information - Schedule of financial information regularly reviewed and used by the CODM (Details)

v3.25.1
Segment Information - Schedule of financial information regularly reviewed and used by the CODM (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenues and other income    
Grant income $ 0 $ 260,501
Research and development (excluding share-based compensation) expense:    
PAH 1,672,869 0
PD 9,333,359 9,036,750
Other programs 1,512,151 4,421,520
Selling, general and administrative (excluding share-based compensation) 7,930,072 6,391,875
Share-based compensation expense 8,140,617 500,148
Total costs and expenses 28,589,068 20,350,293
Loss from operations (28,589,068) (20,089,792)
Interest income 1,069,182 1,060,909
Net loss $ (27,519,886) $ (19,028,883)